Apr 21, 2025
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - HDFC Pharma and Healthcare Fund - Regular (G) | -1.12 | -1.41 | 30.2 | 0 |
| Benchmark - S&P BSE Healthcare TRI | -1.88 | 10.85 | 37 | 11.94 |
| Category Average - BEST EQUITY PERFORMERS | 2.72 | -7.52 | 8.89 | 16.58 |
| Category Rank | 9/10 | 7/10 | 7/10 | 7/10 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal Digital India Fund - Regular (G) | 8.7512 | 2.54 | 0.00 | 0.00 | 0.00 | 677.14 | 2.32 | 500.00 | invest |
| Motilal Oswal Digital India Fund - Regular (IDCW) | 8.7512 | 2.54 | 0.00 | 0.00 | 0.00 | 677.14 | 2.32 | 500.00 | invest |
| Quant Teck Fund - Regular (G) | 11.7759 | 2.51 | -0.40 | 0.00 | 0.00 | 373.03 | 2.43 | 5,000.00 | invest |
| Quant Teck Fund - Regular (IDCW) | 11.7777 | 2.51 | -0.39 | 0.00 | 0.00 | 373.03 | 2.43 | 5,000.00 | invest |
| Nippon India US Equity Opportunities Fund (G) | 29.8972 | -2.61 | 0.65 | 8.25 | 13.55 | 670.53 | 2.39 | 100.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Feb 28, 2025 | 176.08 | 11.99 | -8.64 |
|
| Equity-Divi`s Lab. | Feb 28, 2025 | 130.93 | 8.91 | -1.75 |
|
| Equity-Cipla | Feb 28, 2025 | 114.62 | 7.80 | -4.86 |
|
| Equity-Lupin | Feb 28, 2025 | 81.80 | 5.57 | -2.55 |
|
| Equity-Max Healthcare | Feb 28, 2025 | 71.53 | 4.87 | -7.84 |
|
| Equity-Torrent Pharma. | Feb 28, 2025 | 54.13 | 3.69 | -9.82 |
|
| Equity-Krishna Institu. | Feb 28, 2025 | 53.81 | 3.66 | -14.47 |
|
| Equity-Aurobindo Pharma | Feb 28, 2025 | 49.03 | 3.34 | 0.02 |
|
| Equity-Aster DM Health. | Feb 28, 2025 | 48.15 | 3.28 | -18.02 |
|
| Equity-Ipca Labs. | Feb 28, 2025 | 48.07 | 3.27 | -6.09 |
|
HDFC Mutual Fund has announced change in fund manager under the following s...
HDFC Mutual Fund has announced 17 April 2025 as the record date for declara...
HDFC Mutual Fund has approved the merger of HDFC FMP 1162D March 2022 � Ser...
HDFC Mutual Fund has announced change in Fund Manager of the following sche...
HDFC Mutual Fund has announced change in fund manager under the following s...
HDFC Mutual Fund has announced 20 March 2025 as the record date for declara...
| AMC Name | : | HDFC Mutual Fund |
| Fund Name | : | HDFC Pharma and Healthcare Fund - Regular (G) |
| Contact Persone | : | Nikhil Mathur |
| Registered Address | : | HDFC House, 2nd Flr, H.T.Parekh Marg,165-166, Backbay Reclamation,Churchgate, Mumbai - 400 020. |
| Telephone No | : | 022 - 6631 6333 |
| Fax No. | : | 022 - 22821144 |
| : | hello@hdfcfund.com | |
| Website | : | www.hdfcfund.com |
Top Mutual Funds
